Shenyang Northern Hospital

NCT07388420

No phase, Recruiting, 2026, 60 people, 5 Feb 2026, clinicaltrials.gov

Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis

Phase 4, Recruiting, 2026, 120 people, 23 Jan 2026, clinicaltrials.gov

NCT07351643

Phase 4, Not yet recruiting, 2026, 110 people, 20 Jan 2026, clinicaltrials.gov

NCT05193071

Phase 4, Completed, 2022, 1,022 people, 14 Jan 2022, clinicaltrials.gov

NCT04420351

Collaborator, Phase 3, Completed, 2020, 1,005 people, 9 Jun 2020, clinicaltrials.gov

NCT03753555

Phase 4, Recruiting, 2018, 100 people, 27 Nov 2018, clinicaltrials.gov

NCT03661411

Phase 4, Completed, 2018, 760 people, 7 Sept 2018, clinicaltrials.gov

NCT03536611

Phase 4, Status unknown, 2018, 1,120 people, 24 May 2018, clinicaltrials.gov

NCT03526367

Phase 4, Withdrawn, 2019, 0 people, 16 May 2018, clinicaltrials.gov

NCT03431142

Phase 4, Completed, 2018, 7,758 people, 13 Feb 2018, clinicaltrials.gov

NCT03198741

Phase 4, Completed, 2017, 783 people, 26 Jun 2017, clinicaltrials.gov

NCT03123445

Collaborator, Phase 2, Status unknown, 2017, 150 people, 21 Apr 2017, clinicaltrials.gov

NCT02869009

Phase 3, Completed, 2016, 3,000 people, 16 Aug 2016, clinicaltrials.gov

NCT02203253

Collaborator, Phase 3, Completed, 2014, 642 people, 29 Jul 2014, clinicaltrials.gov

NCT01696110

Phase 4, Completed, 2012, 2,194 people, 28 Sept 2012, clinicaltrials.gov

NCT01094457

Phase 4, Completed, 2009, 840 people, 29 Mar 2010, clinicaltrials.gov

NCT00786136

Phase 4, Completed, 2008, 2,998 people, 6 Nov 2008, clinicaltrials.gov